These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 20591218)
1. Establishment and biological characteristics of oxaliplatin-resistant human colon cancer cell lines. Liu Z; Qiu M; Tang QL; Liu M; Lang N; Bi F Chin J Cancer; 2010 Jul; 29(7):661-7. PubMed ID: 20591218 [TBL] [Abstract][Full Text] [Related]
2. [Correlation of chemosensitivity tested using histoculture drug response assay to expression of multidrug resistance genes and proteins in colorectal cancer tissues]. Yuan SQ; Zhou ZW; Liang YJ; Fu LW; Chen G; Qiu HB; Zhang LY Ai Zheng; 2009 Sep; 28(9):932-8. PubMed ID: 19728910 [TBL] [Abstract][Full Text] [Related]
3. [MiR-145 inhibits drug resistance to Oxaliplatin in colorectal cancer cells through regulating G protein coupled receptor 98]. Fu Q; Cheng J; Zhang J; Zhang Y; Chen X; Xie J; Luo S Zhonghua Wei Chang Wai Ke Za Zhi; 2017 May; 20(5):566-570. PubMed ID: 28534337 [TBL] [Abstract][Full Text] [Related]
4. Anti-tumor effects of CIK combined with oxaliplatin in human oxaliplatin-resistant gastric cancer cells in vivo and in vitro. Zhao Q; Zhang H; Li Y; Liu J; Hu X; Fan L J Exp Clin Cancer Res; 2010 Aug; 29(1):118. PubMed ID: 20799994 [TBL] [Abstract][Full Text] [Related]
5. [The effect of small GTPase Cdc42 on the multidrug resistance of oxaliplatin-resistant colon cancer cell lines]. Li NJ; Liu Z; Zhang Y; Yue CX; Wei W; Li LL; Tang QL; Bi F Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Jul; 42(4):466-70. PubMed ID: 21866627 [TBL] [Abstract][Full Text] [Related]
6. [Effect and mechanism of DNMT inhibitor on the reversal of multidrug resistance in human colon cancer cell line sw620/L-OHP]. Deng Q; Li ZP; Huang CM; Liu Z; Zhong RM; Li AJ; Bi F; Tang QL Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Nov; 41(6):975-9. PubMed ID: 21265097 [TBL] [Abstract][Full Text] [Related]
7. Establishment of a cisplatin-induced multidrug resistance cell line SK-Hep1/DDP. Zhou Y; Ling XL Chin J Cancer; 2010 Feb; 29(2):167-71. PubMed ID: 20109345 [TBL] [Abstract][Full Text] [Related]
8. Induction of epithelial-mesenchymal transition and down-regulation of miR-200c and miR-141 in oxaliplatin-resistant colorectal cancer cells. Tanaka S; Hosokawa M; Yonezawa T; Hayashi W; Ueda K; Iwakawa S Biol Pharm Bull; 2015; 38(3):435-40. PubMed ID: 25757925 [TBL] [Abstract][Full Text] [Related]
9. Establishment and gene analysis of an oxaliplatin-resistant colon cancer cell line THC8307/L-OHP. Tang H; Liu YJ; Liu M; Li X Anticancer Drugs; 2007 Jul; 18(6):633-9. PubMed ID: 17762391 [TBL] [Abstract][Full Text] [Related]
10. Mechanistic analysis of taxol-induced multidrug resistance in an ovarian cancer cell line. Wang NN; Zhao LJ; Wu LN; He MF; Qu JW; Zhao YB; Zhao WZ; Li JS; Wang JH Asian Pac J Cancer Prev; 2013; 14(9):4983-8. PubMed ID: 24175763 [TBL] [Abstract][Full Text] [Related]
11. FTY720 enhances chemosensitivity of colon cancer cells to doxorubicin and etoposide via the modulation of P-glycoprotein and multidrug resistance protein 1. Xing Y; Wang ZH; Ma DH; Han Y J Dig Dis; 2014 May; 15(5):246-59. PubMed ID: 24868599 [TBL] [Abstract][Full Text] [Related]
12. Establishment and biological analysis of the EC109/CDDP multidrug-resistant esophageal squamous cell carcinoma cell line. Wen J; Zheng B; Hu Y; Zhang X; Yang H; Luo KJ; Zhang X; Li YF; Fu JH Oncol Rep; 2009 Jul; 22(1):65-71. PubMed ID: 19513506 [TBL] [Abstract][Full Text] [Related]
13. Oxaliplatin in treatment of the cisplatin-resistant MKN45 cell line of gastric cancer. Tozawa K; Oshima T; Kobayashi T; Yamamoto N; Hayashi C; Matsumoto T; Miwa H Anticancer Res; 2008; 28(4B):2087-92. PubMed ID: 18751380 [TBL] [Abstract][Full Text] [Related]
14. Identification of GAS1 as an epirubicin resistance-related gene in human gastric cancer cells with a partially randomized small interfering RNA library. Zhao L; Pan Y; Gang Y; Wang H; Jin H; Tie J; Xia L; Zhang Y; He L; Yao L; Qiao T; Li T; Liu Z; Fan D J Biol Chem; 2009 Sep; 284(39):26273-85. PubMed ID: 19638344 [TBL] [Abstract][Full Text] [Related]
15. Multidrug resistant lncRNA profile in chemotherapeutic sensitive and resistant ovarian cancer cells. Xu J; Wu J; Fu C; Teng F; Liu S; Dai C; Shen R; Jia X J Cell Physiol; 2018 Jun; 233(6):5034-5043. PubMed ID: 29219179 [TBL] [Abstract][Full Text] [Related]
16. [Sensitivity to chemotherapeutic drugs of polyploid tumor cells induced by a spindle poison nocodazole]. Hao J; Yuan BB; Xu YF; Yu J; Liu GY; Wang DH Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):419-24. PubMed ID: 22967442 [TBL] [Abstract][Full Text] [Related]
17. Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics. Calcagno AM; Salcido CD; Gillet JP; Wu CP; Fostel JM; Mumau MD; Gottesman MM; Varticovski L; Ambudkar SV J Natl Cancer Inst; 2010 Nov; 102(21):1637-52. PubMed ID: 20935265 [TBL] [Abstract][Full Text] [Related]
19. [Effects of medicated serum prepared with Chinese herbal medicine Changweiqing on pharmacokinetics of oxaliplatin in colon cancer cells]. Zhang Y; Sun XW; Xu JH; Lu H; Fan ZZ; Sun J; Zhang XX Zhong Xi Yi Jie He Xue Bao; 2012 Aug; 10(8):901-10. PubMed ID: 22883407 [TBL] [Abstract][Full Text] [Related]
20. Increased expression of an ATP-binding cassette superfamily transporter, multidrug resistance protein 2, in human colorectal carcinomas. Hinoshita E; Uchiumi T; Taguchi K; Kinukawa N; Tsuneyoshi M; Maehara Y; Sugimachi K; Kuwano M Clin Cancer Res; 2000 Jun; 6(6):2401-7. PubMed ID: 10873092 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]